Illness	Number of cases
Hyperplasia of prostate (N40)	387
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	315
Malignant neoplasm of prostate (C61)	308
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	266
Obstructive and reflux uropathy - Crossing vessel and stricture of ureter without hydronephrosis (N13.5)	213
Obstructive and reflux uropathy - Hydronephrosis with ureteral stricture not elsewhere classified (N13.1)	182
Calculus of kidney and ureter - Calculus of kidney (N20.0)	171
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2)	127
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	121
Other symptoms and signs involving the urinary system (R39.1)	107

Top 10 treatments

Treatment	Number
Examination of the urethra and the urinary bladder by endoscopy (1-661)	1.523
Injection or administration of medicines into the urinary bladder (8-132.3)	1.450
(5-98k.0)	1.277
X-rays of the kidney and urinary tract with contrast medium (3-13d.5)	1.236
Insertion, exchange or removal of a ureteral stent (8-137.00)	634
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40)	620
Insertion, exchange or removal of a ureteral stent (8-137.10)	598
(9-984.7)	237
(8-137.20)	222
Surgical removal or destruction of prostatic tissue through the urethra (5-601.0)	218

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
12	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
12	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
12	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Doctoral supervision	Die Betreuung angehender Doktoranden erfolgt durch Prof. Dr. med. Johannes M. Wolff, M. Sc.
Student training (clinical traineeship / internship year)
Lectureships / teaching posts at colleges and universities	Wir bieten Ärzten in unserer Klinik eine strukturierte Weiterbildung zum Facharzt an. Herr Prof. Dr. med. Joh. M. Wolff M. Sc., Chefarzt der Urologie, ist durch seine Zusatzbezeichnungen f. Andrologie und Chemotherapie u.a. mit Befugnis zur Facharztweiterbildung Urologie, Ihr Ansprechpartner.

Training

No.	Training in other healing professions	Comment
HB19	Nursing professionals
HB07	Surgical technical assistant (m/f)
HB13	Medical technical assistant for functional diagnostics (MTAF) (m/f)
HB15	Anaesthesia technical assistant (m/f)